肌肉减少症对急性肠系膜缺血患者的影响评估
本研究回顾性纳入法国尼斯大学医院80例连续急性肠系膜缺血患者,通过CT测量总腰大肌面积/身高(TPA/H)定义肌肉减少症(最低性别特异性四分位数)。结果显示肌肉减少症组与非肌肉减少症组在血运重建率、肠切除需求及30天死亡率上均无显著差异。TPA/H与中性粒细胞、血小板、单核细胞计数呈负相关,与血红蛋白浓度和肾小球滤过率呈正相关。
要点
- 肌肉减少症定义阈值:男性TPA/H <406.1 mm²/m²,女性<307 mm²/m²。
- 肌肉减少症组与非肌肉减少症组30天死亡率分别为63.2%和47.5%,差异无统计学意义(P=0.297)。
- TPA/H与中性粒细胞、血小板、单核细胞计数呈负相关(r分别为-0.283、-0.288、-0.225,P<0.05)。
核心结论
- 肌肉减少症与急性肠系膜缺血患者的30天死亡率、血运重建率及肠切除需求无显著关联。
- TPA/H与部分炎症及营养相关生物标志物存在相关性,但其预后价值需更长随访研究进一步明确。
研究设计与样本
- 回顾性纳入法国尼斯大学医院连续收治的急性肠系膜缺血患者80例。
- 通过CT测量总腰大肌面积并除以身高(TPA/H),以最低性别特异性四分位数定义肌肉减少症。
- 比较肌肉减少症组与非肌肉减少症组的管理方式和30天结局,并分析TPA/H与生物学特征的相关性。
主要发现
- 肌肉减少症组与非肌肉减少症组血运重建率分别为10.5%和26.2%,差异无统计学意义(P=0.214)。
- 肌肉减少症组与非肌肉减少症组肠切除需求分别为26.3%和47.5%,差异无统计学意义(P=0.118)。
- 肌肉减少症组与非肌肉减少症组30天死亡率分别为63.2%和47.5%,差异无统计学意义(P=0.297)。
- TPA/H与中性粒细胞计数(r=-0.283)、血小板计数(r=-0.288)、单核细胞计数(r=-0.225)呈显著负相关(P<0.05)。
- TPA/H与血红蛋白浓度(r=0.368)和肾小球滤过率(r=0.261)呈显著正相关(P<0.05)。
关键数值与推荐
- 肌肉减少症定义为TPA/H低于性别特异性最低四分位数:男性406.1 mm²/m²,女性307 mm²/m²。
临床怎么用
- 对于急性肠系膜缺血患者,CT测量的TPA/H可评估肌肉减少症,但本研究未显示其与30天结局显著相关。
- TPA/H与炎症及肾功能指标相关,或可辅助综合评估患者状态,但尚不能作为预后判断的独立依据。
局限性
- 本研究为回顾性单中心研究,样本量80例。
- 随访时间仅30天,作者建议需更长随访期研究以充分理解肌肉减少症的预后价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcopenia has been identified as a prognostic factor in several diseases. The aim of this study was to investigate the impact of sarcopenia in patients with acute mesenteric ischemia. METHODS: Consecutive patients admitted for acute mesenteric ischemia were retrospectively included at the University Hospital of Nice. Sarcopenia was assessed by the measurement of total psoas area normalized for height (TPA/H) on CT-scan and was defined as a TPA/H inferior to the lowest sex-specific quartile. The management of the patients and the 30-day outcomes were compared between sarcopenic and nonsarcopenic patients. Correlations between the TPA/H and biological characteristics were investigated. RESULTS: Among the 80 patients included, the lowest quartile of TPA/H that defined sarcopenia was 406.1 mm2/m2 for men and 307 mm2/m2 for women. The rate of revascularization or the need of intestinal resection did not significantly differ between sarcopenic and nonsarcopenic patients (10.5% vs. 26.2%, P = 0.214 and 26.3% vs. 47.5%, P = 0.118 respectively). The 30-day mortality did not significantly differ between the two groups (63.2% vs. 47.5%, P = 0.297). The TPA/H was significantly negatively correlated with the neutrophil, thrombocyte, and monocyte counts (r = -0.283; -0.288, -0.225, P < 0.05) and positively correlated with the hemoglobin concentration and the glomerular filtration rate (r = 0.368; 0.261, P < 0.05). CONCLUSIONS: Further studies on longer follow-up period would be of interest to fully understand the prognostic value of sarcopenia in patients with acute mesenteric ischemia.
引用
- Lareyre F, Augène E, Chikande J, et al. Evaluation of the Impact of Sarcopenia in Patients with Acute Mesenteric Ischemia. Ann Vasc Surg. 2019. PMID: 31629853. doi:10.1016/j.avsg.2019.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。